Presbyopia - Epidemiology Forecast - 2032

This ‘Presbyopia-Epidemiology Forecast-2032' report delivers an in-depth understanding of presbyopia, historical and forecasted epidemiology as well as presbyopia trends in China.

Presbyopia Disease Understanding

Presbyopia is the gradual loss of near-focusing ability that occurs with age. Most people begin to notice the effects of presbyopia sometime after age 40. This typically comes on between the ages of 40 and 60 as the lenses of the eyes naturally lose elasticity due to the aging process. Presbyopia can be classified by type, including incipient presbyopia, functional presbyopia, absolute presbyopia, premature presbyopia, and nocturnal presbyopia. Age is the major risk factor for the development of presbyopia. However, the condition may occur prematurely due to factors such as trauma, systemic disease, cardiovascular disease, or a drug side effect.

Initial symptoms may be difficulties with prolonged close-up work with tiring (eye strain) of the eyes. This may be worse in dim light. Other common symptoms are delays in focusing at near or distance, ocular discomfort, headache, asthenopia, squinting, fatigue or drowsiness from near work, increased working distance, need for brighter light for reading, and diplopia. The diagnosis is typically based on the medical history to determine the extent of the vision problem, which may show a medication or systemic diseases and disorders that have ocular manifestations. Current clinical management of presbyopia includes off-label treatment using nonsteroidal anti-inflammatory drugs (NSAIDs), parasympathetic agonists, miotic agents, or some other tempering agents. The most commonly used agents are Pilocarpine, Carbachol, Aceclidine, Brimonidine, Nepafenac, etc.

Presbyopia Diagnosis

A basic and comprehensive examination of the eye with different tests is necessary to diagnose presbyopia. The ophthalmologist examines the retina and conducts muscle integrity, refraction, slit-lamp, visual field, and visual acuity tests. These will help ascertain the condition. Eye drops used during this process to dilate the pupils will cause patients to experience increased sensitivity to light in the few hours following the examinations.

With the help of an ophthalmoscope, the specialist can evaluate the retina, optic disk, and choroid (i.e., a layer of blood vessels responsible for providing nourishment to the retina). A muscle integrity test is done with a moving object, and the ability to follow this object is evaluated. Refractive tests assess how well light waves are bent as they go through the cornea and the lens, and the results of these tests help determine which lens prescription will be needed.

Presbyopia Epidemiology Perspective

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by total prevalent cases of Presbyopia, total diagnosed cases of Presbyopia, age-specific cases of Presbyopia, gender-specific cases of Presbyopia, and severity-specific cases of Presbyopia, the scenario of Presbyopia in China from 2019 to 2032.

Presbyopia Detailed Epidemiology Segmentation

• According to the publisher analysis, China accounted for 329,861,640 Presbyopia prevalent cases in the year 2021. These cases are estimated to rise by the year 2032.
• China accounted for 282,919,791 Presbyopia diagnosed cases in the year 2021, which are expected to rise by 2032.
• In China, the total age-specific cases of Presbyopia were 77,066,373, 107,043,777, 67,159,677, and 31,649,963 cases for the age group 40-49 years, 50-59 years, 60-69 years, and ≥70 years, respectively in the year 2021.
• In China, the total gender-specific cases of Presbyopia were 124,155,342 and 158,764,448 cases for males and females, respectively in the year 2021.
• In China, the total severity-specific cases of Presbyopia were 84,875,937 and 198,043,854 cases for mild cases and moderate to severe cases, respectively in the year 2021.

Scope of the Report

• The report covers the descriptive overview of Presbyopia, explaining its symptoms, grading, pathophysiology, and various diagnostic approaches.
• The report provides insight into China's historical and forecasted patient pool.
• The report assesses the disease risk and burden of Presbyopia.
• The report helps to recognize the growth opportunities in China concerning the patient population.
• The report provides the segmentation of the disease epidemiology for China, a total number of prevalent cases of Presbyopia, diagnosed cases of Presbyopia, age-specific cases of Presbyopia, gender-specific cases of Presbyopia, and severity-specific cases of Presbyopia.

Report Highlights

• 11-Year Forecast of Presbyopia
• China Coverage
• Total prevalent cases of Presbyopia
• Diagnosed cases of Presbyopia
• Age-specific cases of Presbyopia
• Gender-specific cases of Presbyopia
• Severity-specific cases of Presbyopia

Key Questions Answered

• What are the disease risk and burdens of Presbyopia?
• What is the historical Presbyopia patient pool in China?
• What will be the growth opportunities across China concerning the patient population with Presbyopia?
• At what CAGR the population is expected to grow across China during the forecast period (2022-2032)?

Reasons to Buy

The Presbyopia report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving China's Presbyopia epidemiology forecast.
• The Presbyopia epidemiology report and model were written and developed by Master and Ph.D. level epidemiologists.
• The Presbyopia epidemiology model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports the data presented in the report and showcases disease trends over the 11-year forecast period using reputable sources.

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Geographies Covered

• China

Study Period: 2019-2032